Aptamer Applications in Neuroscience


Ozturk M., Nilsen-Hamilton M., Ilgu M.

PHARMACEUTICALS, vol.14, no.12, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 12
  • Publication Date: 2021
  • Doi Number: 10.3390/ph14121260
  • Journal Name: PHARMACEUTICALS
  • Journal Indexes: Science Citation Index Expanded, Scopus, Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals
  • Keywords: aptamer, neuroscience, neurological diseases, neurological disorders, neurotoxins, cancer, IN-VITRO SELECTION, SURFACE-PLASMON RESONANCE, NUCLEIC-ACID APTAMERS, DNA-APTAMER, RNA APTAMERS, CAPILLARY-ELECTROPHORESIS, HUNTINGTONS-DISEASE, MUTANT HUNTINGTIN, RECENT TRENDS, DOPAMINE

Abstract

Being the predominant cause of disability, neurological diseases have received much attention from the global health community. Over a billion people suffer from one of the following neurological disorders: dementia, epilepsy, stroke, migraine, meningitis, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, prion disease, or brain tumors. The diagnosis and treatment options are limited for many of these diseases. Aptamers, being small and non-immunogenic nucleic acid molecules that are easy to chemically modify, offer potential diagnostic and theragnostic applications to meet these needs. This review covers pioneering studies in applying aptamers, which shows promise for future diagnostics and treatments of neurological disorders that pose increasingly dire worldwide health challenges.